Rationale: The role of dietary lipids in host-microbiome research has for a long time been overlooked; as high lipid intake has been recently indicated to have the most pronounced effect on the small intestinal microbiome, fecal-oriented studies might have missed their important, local effect. Indications for an interaction between dietary lipids and the small intestinal microbiome are mainly based on animal studies, but human data are largely missing. This study therefore aims at exploring this principal in vivo in healthy individuals. Primary objective: To assess the effect of dietary lipids on the small intestinal microbiome in humans (proof-of-concept), the primary objective of our study is to measure production of microbiota-derived lipid metabolites in the human small intestine after consumption of a plant-based high-fat shake in healthy pre-conditioned subjects. Secondary objectives: To explore future perspectives for dietary lipid - small intestinal microbiome interactive research, the secondary objectives of our study are 1. To compare the levels of microbiota-derived lipid metabolites in aspirate samples obtained through a naso-intestinal catheter (golden standard; invasive sampling method) and an aspiration capsule (less invasive, innovative sampling method), and in blood (local versus systemic effect) and feces (small intestinal versus fecal effect; less invasive sampling); 2. To investigate the acute effect of a high-fat shake on the composition and transcriptome activity of the small intestine microbiota in aspirate samples of healthy pre-conditioned subjects; 2a) To compare the acute effects on the small intestine microbiota composition in aspirate samples obtained through a naso-intestinal catheter versus those obtained via an aspiration capsule; 3. To study and compare the effect of a 8-day plant-based mild ketogenic preconditioning diet on the composition of the small intestine microbiota (aspiration capsule) and the fecal microbiota. Study design: Proof-of-concept intervention study Study population: 16 healthy adults, BMI between 18.5-30 kg/m2. Intervention: 8-days preconditioning mild ketogenic controlled diet followed by a high fat shake challenge with a naso-intestinal catheter. Main study parameters/endpoints: The primary study parameters are the microbial-derived metabolites from linoleic acid and plant sterols after consumption of the high fat shake. Secondary study parameters include microbiota composition and transcriptome activity. Other parameters include inflammatory markers and ex-vivo analyses.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
16
Plant-based mild ketogenic diet (10-20EN% carbohydrates, 10-20EN% protein, and 60-70EN% fat), consisting of a daily breakfast, lunch, dinner, and snacks.
The high-fat shake consists of unsweetened almond milk, sunflower oil, and plant sterols, resulting in a shake containing 885 kcal (1.5g protein, 97.3g fat, and 0.8g sugar).
Wageningen University
Wageningen, Gelderland, Netherlands
lipid metabolites from linoleic acid and plant sterols in the small intestine aspirates
Concentrations of microbiota-derived lipid metabolites in the small intestine aspirates, obtained by a naso-intestinal catheter, measured by lipidomics.
Time frame: 0-6 hours
lipid metabolites in small intestine aspirate samples obtained with an aspiration capsule.
Concentrations of microbiota-derived lipid metabolites in the small intestine aspirates, obtained by an aspiration capsule, measured by lipidomics.
Time frame: 0-6 hours
small intestine microbiota composition
The relative composition (%) of the small intestine microbiota in aspirate samples obtained by an intestinal catheter.
Time frame: 0-6 hours
small intestine microbiome capacity
The functional capacity (transcriptomic activity) of the small intestine microbiota in aspirate samples obtained by an intestinal catheter.
Time frame: 0-6 hours
Faecal microbiota
The relative composition (%) of the faecal microbiota
Time frame: Baseline, after 8 days.
Blood lipid metabolites
Lipid metabolites (HYA, CLA, all untargeted lipid metabolites) will be measured in blood samples with lipidomics.
Time frame: 0-6 hours
Blood triglycerides
Concentrations of triglycerides
Time frame: 0-6 hours
Blood free fatty acids
Concentrations of free fatty acids
Time frame: 0-6 hours
small intestine microbiota
The relative composition (%) of the small intestine microbiota in aspirates obtained by an aspiration capsule.
Time frame: Baseline, after 5 days.
small intestine microbiome
The functional capacity (transcriptomic activity) of the small intestine microbiota in aspirates obtained by an aspiration capsule.
Time frame: Baseline, after 5 days.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.